Effect of a Casein and Gluten Free Diet in Mexican Children With Autism Spectrum Disorder
1 other identifier
interventional
20
1 country
1
Brief Summary
Assess the effect of a casein-free and gluten-free diet on gastrointestinal symptoms, clinical variables, and the composition of the intestinal microbiota in Mexican children with autism spectrum disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 12, 2024
CompletedFirst Submitted
Initial submission to the registry
August 1, 2024
CompletedFirst Posted
Study publicly available on registry
August 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedAugust 16, 2024
August 1, 2024
11 months
August 1, 2024
August 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Gut microbiota composition through Next Generation Sequencing (16SRNA) and bioinformatic analysis
The composition of the intestinal microbiota will be sequenced, and gastrointestinal symptoms will be characterized before and after the nutritional intervention.
12 weeks
Study Arms (1)
Nutritional Intervention
EXPERIMENTALGroup with 3 months of a gluten free and casein free diet
Interventions
Parents will be advised for three months to ensure that children with autism spectrum disorder follow a casein-free and gluten-free diet during this period.
Eligibility Criteria
You may qualify if:
- Children between 4-10 years old diagnosed with autism spectrum disorder using the criteria established in the ADOS scale and the CARS.
You may not qualify if:
- Children who have received:
- Antibiotics
- Antimycotics
- Probiotic supplements
- Prebiotic supplements
- Any medication that may alter the microbial composition of the patient, minimum one month prior to sampling.
- Children on a strict dietary regimen other than a casein-free and gluten-free diet.
- Children with celiac disease or who present any gluten-related disorder.
- Children with allergy to dairy products.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara
Guadalajara, Jalisco, 44340, Mexico
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nora M. Torres Carrillo, Ph.D.
University of Guadalajara
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PH.D. In Biomedical Sciences, Tenured Research Professor A
Study Record Dates
First Submitted
August 1, 2024
First Posted
August 16, 2024
Study Start
February 12, 2024
Primary Completion
December 31, 2024
Study Completion
July 31, 2025
Last Updated
August 16, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share